Want to join the conversation?
$XRAY's full-year 2015 sales, excluding precious metals fell 7.6% vs. 2014, as 2% internal growth was offset by headwinds from currency translation of 950 BP & net acquisition divestitures of 10 BP. Internal growth included a headwind from discontinued products of approx. 50 BP globally, with growth in US of 3.1%, Europe of (0.3%) and RoW of 4.9%.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)